NSA, as a GSDMD‐targeted inhibitor, can inhibit pyroptosis by inhibiting GSDMD, thereby alleviating a variety of inflammatory diseases, such as inflammatory bowel disease,360 acute liver failure,361 and pulmonary fibrosis362 and is expected to alleviate inflammation related to MDs. Here, GSDMD is linked to myelodysplastic syndrome.